Skip to main content

Table 4 Univariate and multivariate analysis for progression-free survival

From: Biomarker analysis for patients with pancreatic cancer treated with nanoliposomal irinotecan plus 5-fluorouracil/leucovorin

Univariate analysis

Multivariate analysis

Variables

HR

95% CI

P value

HR

95% CI

P value

Age (years)

≤65 vs. > 65

0.81

0.42–1.55

0.521

   

ECOG PS

0–1 vs. 2

1.13

0.35–3.69

0.837

   

Liver metastasis

− vs. +

1.17

0.60–2.29

0.652

   

Prior irinotecan

− vs. +

1.45

0.64–3.29

0.372

2.33

0.92–5.91

0.075

NLR

≤5 vs. > 5

2.26

1.10–4.67

0.027

2.67

1.09–6.53

0.032

GPS

0 vs. 1–2

2.17

1.17–4.02

0.014

2.16

1.09–4.30

0.028

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us